Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    24434091 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Bexarotene Augmentation of Antipsychotic Treatment for Chronic Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Bexarotene (Targretin LGD1069);   Drug: bexarotene

Study has passed its completion date and status has not been verified in more than two years.